Atlas Trials

Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease

Clinical trial NCT02221947 · TERMINATED

Trial details

NCT number
NCT02221947
Sponsor
Neurotrope Bioscience, Inc.
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2014-06-01
Primary completion
2014-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.